摘要:
The invention is directed to physiologically active compounds of general formula (I):— and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.
摘要:
The invention is directed to physiologically active compounds of general formula (I): and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.
摘要:
The invention is directed to physiologically active compounds of general formula (I):— and compositions containing such compounds; and their prodrugs, and pharmaceutically acceptable salts and solvates of such compounds and their prodrugs, as well as to novel compounds within the scope of formula (I). Such compounds and compositions have valuable pharmaceutical properties, in particular the ability to inhibit kinases.
摘要:
The present invention discloses and claims benzimidazole compounds of formula (I): in which A is aryl or heteroaryl; R1 is sleceted from optionally substituted alkyl, alkoxy, aryl or heteroaryl, NH-lower alkyl or NH-cycloalkyl, or halogen, NH2; 1-imidazolyl or SO2Me; R2 is selected from optionally substituted —CO-alkyl, —CO-cycloalkyl, —CO-aralkyl, —CO-aryl, —CO-alkoxy, aryl or aralkyl, or —O-amino, CO—NHR3 or CO—R3R4 wherein R3 and R4 are selecteded independently from hydrogen, alkyl, hydroxyalkyl, alkoxyalkyl, fluoroalkyl, alkynyl, heteroalkyl, alkylheteroalkyl, aryl, aralkyl or together form an alkylene chain optionally containing one to 4 heteroatoms; a pharmaceutically acceptable salt or a prodrug thereof; the use of compounds of formula (I) for the treatment of cancer, and pharmaceutical compositions comprising a compound of formula (I) and one or more pharmaceutically acceptable adjuvants or diluents.
摘要翻译:本发明公开并要求式(I)的苯并咪唑化合物:其中A是芳基或杂芳基; R 1从任选取代的烷基,烷氧基,芳基或杂芳基,NH-低级烷基或NH-环烷基取代,或卤素,NH 2; 1-咪唑基或SO2Me; R 2选自任选取代的-CO-烷基,-CO-环烷基,-CO-芳烷基,-CO-芳基,-CO-烷氧基,芳基或芳烷基,或-O-氨基,CO-NHR3或CO-R3R4,其中R3 烷基,羟基烷基,烷氧基烷基,氟代烷基,炔基,杂烷基,烷基杂烷基,芳基,芳烷基或一起形成任选含有1至4个杂原子的亚烷基链; 其药学上可接受的盐或其前药; 使用式(I)化合物治疗癌症,以及包含式(I)化合物和一种或多种药学上可接受的佐剂或稀释剂的药物组合物。
摘要:
The present invention discloses and claims benzimidazole compounds of formula (I): in which A is aryl or heteroaryl; R1 is selected from optionally substituted alkyl, alkoxy, aryl or heteroaryl, NH-lower alkyl or NH-cycloalkyl, or halogen, NH2; 1-imidazolyl or SO2Me; R2 is selected from optionally substituted —CO-alkyl, —CO-cycloalkyl, —CO-aralkyl, —CO-aryl, —CO-alkoxy, aryl or aralkyl, or —CO-amino, CO—NHR3 or CO—R3R4 wherein R3 and R4 are selecteded independently from hydrogen, alkyl, hydroxyalkyl, alkoxyalkyl, fluoroalkyl, alkynyl, heteroalkyl, alkylheteroalkyl, aryl, aralkyl or together form an alkylene chain optionally containing one to 4 heteroatoms; a pharmaceutically acceptable salt or a prodrug thereof; the use of compounds of formula (I) for the treatment of cancer, and pharmaceutical compositions comprising a compound of formula (I) and one or more pharmaceutically acceptable adjuvants or diluents.
摘要翻译:本发明公开并要求式(I)的苯并咪唑化合物:其中A是芳基或杂芳基; R 1选自任选取代的烷基,烷氧基,芳基或杂芳基,NH-低级烷基或NH-环烷基,或卤素,NH 2。 1-咪唑基或SO 2 Me; R 2选自任选取代的-CO-烷基,-CO-环烷基,-CO-芳烷基,-CO-芳基,-CO-烷氧基,芳基或芳烷基或-CO-氨基,CO -NHR 3或CO-R 3 R 4其中R 3和R 4 SUB 烷基,羟基烷基,烷氧基烷基,氟代烷基,炔基,杂烷基,烷基杂烷基,芳基,芳烷基或一起形成任选含有一个至四个杂原子的亚烷基链; 其药学上可接受的盐或其前药; 使用式(I)化合物治疗癌症,以及包含式(I)化合物和一种或多种药学上可接受的佐剂或稀释剂的药物组合物。
摘要:
This invention relates to derivatives of 4-(benzimidazol-2-yl)fluorene and 4-(azabenzimidazol-2-yl)fluorene, to pharmaceutical compositions comprising such derivatives, and to methods of treatment of disorders related to Hsp90 protein activity, comprising administering such derivatives.
摘要:
This invention relates to isoindole derivates of Formula I to pharmaceutical compositions comprising such derivatives, and to methods of treatment comprising administering of such derivatives.